Merck Life Science A/S — Credit Rating and Financial Key Figures

Merck Life Science A/S (CVR number: 20830131) is a company from GLADSAXE. The company reported a net sales of 1398.6 mDKK in 2023, demonstrating a growth of 11.3 % compared to the previous year. The operating profit percentage was at 6.6 % (EBIT: 91.7 mDKK), while net earnings were 73.6 mDKK. The profitability of the company measured by Return on Assets (ROA) was 34.3 %, which can be considered excellent and Return on Equity (ROE) was 36.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 74.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Merck Life Science A/S's liquidity measured by quick ratio was 3.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.